1.	A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen Phase: Phase IV Type: Supportive care Status: Closed Age: 21 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: DOCET_L_04775, U1111-1116-9574, NCT01107756
2.	Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: AMLSG 12-09, NCT01180322